scispace - formally typeset
Open AccessJournal ArticleDOI

Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease

Reads0
Chats0
TLDR
All 112 liver biopsied patients had the characteristic pathology, which is progressive, and includes microvesicular steatosis, which leads to fibrosis, micronodular cirrhosis, and ultimately to liver failure.
About
This article is published in Journal of Hepatology.The article was published on 2013-06-01 and is currently open access. It has received 284 citations till now. The article focuses on the topics: Cholesterol ester storage disease & Lysosomal acid lipase deficiency.

read more

Citations
More filters
Journal ArticleDOI

Nonalcoholic fatty liver disease

TL;DR: No effective medical interventions exist that completely reverse the disease other than lifestyle changes, dietary alterations and, possibly, bariatric surgery, however, several strategies that target pathophysiological processes such as an oversupply of fatty acids to the liver, cell injury and inflammation are currently under investigation.
Journal ArticleDOI

Cytosolic lipolysis and lipophagy: two sides of the same coin

TL;DR: This Review discusses how cytosolic 'neutral' lipolysis and lipophagy, which utilizes 'acid'lipolysis in lysosomes, degrade cellular triacylglycerols as well as how these pathways communicate, how they affect lipid metabolism and energy homeostasis and how their dysfunction affects the pathogenesis of metabolic diseases.
Journal ArticleDOI

Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

TL;DR: Practical guidance is provided to lipidologists, endocrinologists, cardiologists and hepatologists on how to recognize individuals with this life-limiting disease and a diagnostic algorithm is proposed with a view to achieving definitive diagnosis using a recently developed blood test for lysosomal acid lipase.
Journal ArticleDOI

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.

TL;DR: Sbelipase alfa therapy resulted in a reduction in multiple disease-related hepatic and lipid abnormalities in children and adults with lysosomal acid lipase deficiency and observed improvements in lipid levels and reduction in hepatic fat content.
References
More filters
Journal ArticleDOI

Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice

TL;DR: In this article, the GENEWARE® expression system (G-hLAL) was used to express human Lysosomal acid lipase (LAL), an essential enzyme that hydrolyzes triglycerides (TGs) and cholesteryl esters (CEs) in lysosomes.
Journal ArticleDOI

Microvesicular Steatosis of the Liver

TL;DR: The concept of "microvesicular fat diseases" as a unique entity seems no longer justified as the different conditions associated with microvesicular steatosis are heterogenous in many aspects.
Journal ArticleDOI

A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin

TL;DR: It is concluded that in two siblings with a novel LAL variant and mild phenotype of CESD, lovastatin decreased both serum lipid concentrations and hepatocellular lysosomal content.
Journal ArticleDOI

Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease

TL;DR: Preliminary anecdotal findings in a CESD patient with novel LIPA mutations support the longer term safety of statins in an adolescent patient and provide new data about the potential efficacy and tolerability of ezetimibe in this patient group.
Journal ArticleDOI

Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.

TL;DR: The results suggest that E8SJM leads to essentially a null allele and that the differences in WD and CESD phenotype involve other factors.
Related Papers (5)